Our Journey so far…

Thoughtfully crafted to elevate what Riron is - a product of the deep science research at Keylika, an early stage biotech startup backed by Y Combinator. A journey that crossed continents, from Europe to the Americas — beginning in Belgium and culminating in the Silicon Valley, California. Then evolving market needs and a series of serendipities opened up a strategy for efficient commercialization, giving birth to Riron - a unique iron supplement. Till date, we have demonstrated strong safety and efficacy in animal studies. Currently, we are working with a GMP-certified manufacturer to transfer our patent-pending nanoformulation for scaling up production.

Our estimated commercial launch in the US is beginning of Q2 2026.